{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T23:24:39Z","timestamp":1782861879857,"version":"3.54.5"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"17","license":[{"start":{"date-parts":[[2023,9,2]],"date-time":"2023-09-02T00:00:00Z","timestamp":1693612800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,9,2]],"date-time":"2023-09-02T00:00:00Z","timestamp":1693612800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Cancer Res Clin Oncol"],"published-print":{"date-parts":[[2023,11]]},"DOI":"10.1007\/s00432-023-05330-9","type":"journal-article","created":{"date-parts":[[2023,9,2]],"date-time":"2023-09-02T11:01:40Z","timestamp":1693652500000},"page":"15671-15677","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Serum THBS2 is a potential biomarker for the diagnosis of non-small cell lung cancer"],"prefix":"10.1007","volume":"149","author":[{"given":"Lang","family":"Xiong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuhai","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mao","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingwei","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,9,2]]},"reference":[{"issue":"10","key":"5330_CR1","doi-asserted-by":"publisher","first-page":"7849","DOI":"10.1007\/s00432-023-04746-7","volume":"149","author":"Y Bao","year":"2023","unstructured":"Bao Y, Yan E, Wang N (2023) Evaluation of GREM1 and THBS2 as prognostic markers in in non-small cell lung cancer. J Cancer Res Clin Oncol 149(10):7849\u20137856","journal-title":"J Cancer Res Clin Oncol"},{"issue":"8","key":"5330_CR2","doi-asserted-by":"publisher","first-page":"2396","DOI":"10.1016\/j.bbagen.2014.01.013","volume":"1840","author":"NE Calabro","year":"2014","unstructured":"Calabro NE, Kristofik NJ, Kyriakides TR (2014) Thrombospondin-2 and extracellular matrix assembly. Biochim Biophys Acta 1840(8):2396\u20132402","journal-title":"Biochim Biophys Acta"},{"issue":"3","key":"5330_CR3","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1016\/j.cllc.2011.03.019","volume":"12","author":"S Cedres","year":"2011","unstructured":"Cedres S, Nunez I, Longo M et al (2011) Serum tumor markers CEA, CYFRA21-1, and CA-125 are associated with worse prognosis in advanced non-small-cell lung cancer (NSCLC). Clin Lung Cancer 12(3):172\u2013179","journal-title":"Clin Lung Cancer"},{"key":"5330_CR4","doi-asserted-by":"publisher","first-page":"153303382096422","DOI":"10.1177\/1533033820964222","volume":"19","author":"L Chen","year":"2020","unstructured":"Chen L, Li Y, Lu J (2020) Identification of Circulating miR-762 as a Novel Diagnostic and Prognostic Biomarker for Non-Small Cell Lung Cancer. Technol Cancer Res Treat 19:1533033820964222","journal-title":"Technol Cancer Res Treat"},{"issue":"54","key":"5330_CR5","doi-asserted-by":"publisher","first-page":"92254","DOI":"10.18632\/oncotarget.21173","volume":"8","author":"W Fei","year":"2017","unstructured":"Fei W, Chen L, Chen J et al (2017) RBP4 and THBS2 are serum biomarkers for diagnosis of colorectal cancer. Oncotarget 8(54):92254\u201392264","journal-title":"Oncotarget"},{"issue":"1","key":"5330_CR6","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1186\/s12885-017-3474-3","volume":"17","author":"Y Gao","year":"2017","unstructured":"Gao Y, Song P, Li H et al (2017) Elevated serum CEA levels are associated with the explosive progression of lung adenocarcinoma harboring EGFR mutations. BMC Cancer 17(1):484","journal-title":"BMC Cancer"},{"issue":"1","key":"5330_CR7","doi-asserted-by":"publisher","first-page":"2155","DOI":"10.1080\/21691401.2019.1620758","volume":"47","author":"T Ge","year":"2019","unstructured":"Ge T, Zhou Y, Lu H (2019) The diagnostic performance of lysine(K)-specific demethylase 6B (KDM6B) in non-small cell lung cancer. Artif Cells Nanomed Biotechnol 47(1):2155\u20132160","journal-title":"Artif Cells Nanomed Biotechnol"},{"issue":"7","key":"5330_CR8","first-page":"CD013382","volume":"7","author":"RG Gijtenbeek","year":"2023","unstructured":"Gijtenbeek RG, de Jong K, Venmans BJ et al (2023) Best first-line therapy for people with advanced non-small cell lung cancer, performance status 2 without a targetable mutation or with an unknown mutation status. Cochrane Database Syst Rev 7(7):CD013382","journal-title":"Cochrane Database Syst Rev"},{"issue":"2","key":"5330_CR9","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1007\/s00432-016-2271-8","volume":"143","author":"M Goto","year":"2017","unstructured":"Goto M, Naito M, Saruwatari K et al (2017) The ratio of cancer cells to stroma after induction therapy in the treatment of non-small cell lung cancer. J Cancer Res Clin Oncol 143(2):215\u2013223","journal-title":"J Cancer Res Clin Oncol"},{"issue":"6","key":"5330_CR10","doi-asserted-by":"publisher","first-page":"2783","DOI":"10.1002\/cam4.1514","volume":"7","author":"D Hang","year":"2018","unstructured":"Hang D, Zhou J, Qin N et al (2018) A novel plasma circular RNA circFARSA is a potential biomarker for non-small cell lung cancer. Cancer Med 7(6):2783\u20132791","journal-title":"Cancer Med"},{"issue":"1","key":"5330_CR11","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1007\/s00432-022-04500-5","volume":"149","author":"G Hong","year":"2023","unstructured":"Hong G, Sun P, Chung C et al (2023) Plasma GDF15 levels associated with circulating immune cells predict the efficacy of PD-1\/PD-L1 inhibitor treatment and prognosis in patients with advanced non-small cell lung cancer. J Cancer Res Clin Oncol 149(1):159\u2013171","journal-title":"J Cancer Res Clin Oncol"},{"issue":"1","key":"5330_CR12","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1186\/s13550-023-00976-5","volume":"13","author":"M Jiang","year":"2023","unstructured":"Jiang M, Chen P, Guo X et al (2023) Identification of EGFR mutation status in male patients with non-small-cell lung cancer: role of (18)F-FDG PET\/CT and serum tumor markers CYFRA21-1 and SCC-Ag. EJNMMI Res 13(1):27","journal-title":"EJNMMI Res"},{"key":"5330_CR13","doi-asserted-by":"publisher","unstructured":"Kim J, Bamlet WR, Oberg AL et al (2017) Detection of early pancreatic ductal adenocarcinoma with thrombospondin-2 and CA19\u20139 blood markers. Sci Transl Med 9(398). https:\/\/doi.org\/10.1126\/scitranslmed.aah5583","DOI":"10.1126\/scitranslmed.aah5583"},{"issue":"19","key":"5330_CR14","doi-asserted-by":"publisher","first-page":"2367","DOI":"10.4155\/bio.12.203","volume":"4","author":"L Liu","year":"2012","unstructured":"Liu L, Liu B, Zhu LL et al (2012) Clinical significance of CYFRA21-1, Scc-Ag and telomerase activity in serum and pleural effusion of patients with squamous-cell lung cancer. Bioanalysis 4(19):2367\u20132374","journal-title":"Bioanalysis"},{"issue":"4","key":"5330_CR15","doi-asserted-by":"publisher","first-page":"591","DOI":"10.2217\/bmm.13.55","volume":"7","author":"L Liu","year":"2013","unstructured":"Liu L, Liu B, Zhu LL et al (2013) CYFRA21-1 as a serum tumor marker for follow-up patients with squamous cell lung carcinoma and oropharynx squamous cell carcinoma. Biomark Med 7(4):591\u2013599","journal-title":"Biomark Med"},{"issue":"3","key":"5330_CR16","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1016\/j.ejcts.2007.05.014","volume":"32","author":"K Matsuoka","year":"2007","unstructured":"Matsuoka K, Sumitomo S, Nakashima N et al (2007) Prognostic value of carcinoembryonic antigen and CYFRA21-1 in patients with pathological stage I non-small cell lung cancer. Eur J Cardiothorac Surg 32(3):435\u2013439","journal-title":"Eur J Cardiothorac Surg"},{"key":"5330_CR17","doi-asserted-by":"publisher","first-page":"6549","DOI":"10.1007\/s00432-023-04631-3","volume":"149","author":"N Melling","year":"2023","unstructured":"Melling N, Reeh M, Ghadban T et al (2023) RAI3 expression is not associated with clinical outcomes of patients with non-small cell lung cancer. J Cancer Res Clin Oncol 149:6549\u20136555. https:\/\/doi.org\/10.1007\/s00432-023-04631-3","journal-title":"J Cancer Res Clin Oncol"},{"issue":"3","key":"5330_CR18","doi-asserted-by":"publisher","first-page":"1828","DOI":"10.3390\/curroncol29030150","volume":"29","author":"H Mithoowani","year":"2022","unstructured":"Mithoowani H, Febbraro M (2022) Non-Small-Cell Lung Cancer in 2022: A Review for General Practitioners in Oncology. Curr Oncol 29(3):1828\u20131839","journal-title":"Curr Oncol"},{"issue":"2","key":"5330_CR19","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/j.ccm.2020.02.008","volume":"41","author":"NJ Myall","year":"2020","unstructured":"Myall NJ, Das M (2020) Advances in the Treatment of Stage III Non-Small Cell Lung Cancer. Clin Chest Med 41(2):211\u2013222","journal-title":"Clin Chest Med"},{"issue":"3","key":"5330_CR20","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1016\/j.jtho.2021.11.003","volume":"17","author":"AG Nicholson","year":"2022","unstructured":"Nicholson AG, Tsao MS, Beasley MB et al (2022) The 2021 WHO Classification of Lung Tumors: Impact of Advances Since 2015. J Thorac Oncol 17(3):362\u2013387","journal-title":"J Thorac Oncol"},{"issue":"6","key":"5330_CR21","doi-asserted-by":"publisher","first-page":"1210","DOI":"10.21037\/tlcr-22-682","volume":"12","author":"KH Patel","year":"2023","unstructured":"Patel KH, Alpert N, Tuminello S et al (2023) Personal and clinical characteristics associated with immunotherapy effectiveness in stage IV non-small cell lung cancer. Transl Lung Cancer Res 12(6):1210\u20131220","journal-title":"Transl Lung Cancer Res"},{"key":"5330_CR22","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/02648725.2023.2216528","volume":"19","author":"L Ren","year":"2023","unstructured":"Ren L, Yang Y (2023) Value of dual-source CT dual-energy parameters combined with serum detection of VEGF and CEA in the diagnosis of early lung cancer. Biotechnol Genet Eng Rev 19:1\u201312","journal-title":"Biotechnol Genet Eng Rev"},{"issue":"4","key":"5330_CR23","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1016\/j.ejcts.2004.01.029","volume":"25","author":"Y Sakao","year":"2004","unstructured":"Sakao Y, Tomimitsu S, Takeda Y et al (2004) Carcinoembryonic antigen as a predictive factor for postoperative tumor relapse in early-stage lung adenocarcinoma. Eur J Cardiothorac Surg 25(4):520\u2013522","journal-title":"Eur J Cardiothorac Surg"},{"issue":"3","key":"5330_CR24","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL et al (2021) Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin 71(3):209\u2013249","journal-title":"CA Cancer J Clin"},{"issue":"2","key":"5330_CR25","doi-asserted-by":"publisher","first-page":"S99","DOI":"10.1016\/j.lungcan.2004.07.985","volume":"45","author":"M Thomas","year":"2004","unstructured":"Thomas M, Hoffknecht P, Droege C et al (2004) Non-small-cell lung cancer: multimodality approach in stage-III resectable disease. Lung Cancer 45(2):S99-105","journal-title":"Lung Cancer"},{"issue":"2","key":"5330_CR26","first-page":"76","volume":"10","author":"M Tomita","year":"2004","unstructured":"Tomita M, Matsuzaki Y, Edagawa M et al (2004) Prognostic significance of preoperative serum carcinoembryonic antigen level in lung adenocarcinoma but not squamous cell carcinoma. Ann Thorac Cardiovasc Surg 10(2):76\u201380","journal-title":"Ann Thorac Cardiovasc Surg"},{"issue":"2","key":"5330_CR27","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1158\/1940-6207.CAPR-20-0403","volume":"14","author":"S Udgata","year":"2021","unstructured":"Udgata S, Takenaka N, Bamlet WR et al (2021) THBS2\/CA19-9 Detecting Pancreatic Ductal Adenocarcinoma at Diagnosis Underperforms in Prediagnostic Detection: Implications for Biomarker Advancement. Cancer Prev Res (phila) 14(2):223\u2013232","journal-title":"Cancer Prev Res (phila)"},{"issue":"6","key":"5330_CR28","doi-asserted-by":"publisher","first-page":"33366","DOI":"10.1038\/srep33366","volume":"16","author":"X Wang","year":"2016","unstructured":"Wang X, Zhang L, Li H et al (2016) THBS2 is a Potential Prognostic Biomarker in Colorectal Cancer. Sci Rep 16(6):33366","journal-title":"Sci Rep"},{"issue":"5","key":"5330_CR29","first-page":"1343","volume":"15","author":"L Wang","year":"2023","unstructured":"Wang L, Feng L, Liu L et al (2023) Joint effect of THBS2 and VCAN accelerating the poor prognosis of gastric cancer. Aging (albany, NY) 15(5):1343\u20131357","journal-title":"Aging (albany, NY)"},{"issue":"8","key":"5330_CR30","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0161007","volume":"11","author":"TY Weng","year":"2016","unstructured":"Weng TY, Wang CY, Hung YH et al (2016) Differential Expression Pattern of THBS1 and THBS2 in Lung Cancer: Clinical Outcome and a Systematic-Analysis of Microarray Databases. PLoS ONE 11(8):e0161007","journal-title":"PLoS ONE"},{"issue":"1","key":"5330_CR31","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1111\/crj.12499","volume":"12","author":"CH Xu","year":"2018","unstructured":"Xu CH, Wang W, Wang YC et al (2018) Diagnosis value of serum soluble B7\u2013H4 expression in non-small cell lung cancer. Clin Respir J 12(1):134\u2013139","journal-title":"Clin Respir J"},{"issue":"15","key":"5330_CR32","doi-asserted-by":"publisher","first-page":"7335","DOI":"10.1111\/jcmm.16762","volume":"25","author":"C Xu","year":"2021","unstructured":"Xu C, Liu W, Li L et al (2021) Serum tumour M2-pyruvate kinase as a biomarker for diagnosis and prognosis of early-stage non-small cell lung cancer. J Cell Mol Med 25(15):7335\u20137341","journal-title":"J Cell Mol Med"},{"issue":"2","key":"5330_CR33","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000009586","volume":"97","author":"B Yuan","year":"2018","unstructured":"Yuan B, Ji W, Fan B et al (2018) Association analysis between thrombospondin-2 gene polymorphisms and intervertebral disc degeneration in a Chinese Han population. Medicine (baltimore) 97(2):e9586","journal-title":"Medicine (baltimore)"},{"issue":"7","key":"5330_CR34","doi-asserted-by":"publisher","first-page":"3649","DOI":"10.1007\/s00432-022-04254-0","volume":"149","author":"Q Zhang","year":"2023","unstructured":"Zhang Q, Qin S, Peng C et al (2023) Circulating circular RNA hsa_circ_0023179 acts as a diagnostic biomarker for non-small-cell lung cancer detection. J Cancer Res Clin Oncol 149(7):3649\u20133660","journal-title":"J Cancer Res Clin Oncol"}],"container-title":["Journal of Cancer Research and Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00432-023-05330-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00432-023-05330-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00432-023-05330-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,27]],"date-time":"2024-10-27T10:56:57Z","timestamp":1730026617000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00432-023-05330-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,2]]},"references-count":34,"journal-issue":{"issue":"17","published-print":{"date-parts":[[2023,11]]}},"alternative-id":["5330"],"URL":"https:\/\/doi.org\/10.1007\/s00432-023-05330-9","relation":{},"ISSN":["0171-5216","1432-1335"],"issn-type":[{"value":"0171-5216","type":"print"},{"value":"1432-1335","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,9,2]]},"assertion":[{"value":"24 July 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 August 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 September 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no conflict of interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The study complied with the Declaration of Helsinki and was approved by the ethical committee of The First Affiliated Hospital of Chengdu Medical College (No. 20823574). Every participant gave their informed written consent to participate in the study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Every participant gave their consent for publication of this work.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}]}}